Leah L Turner

US Patent:

20020172959, Nov 21, 2002

Filed:

Oct 25, 2001

Appl. No.:

10/002344

Inventors:

Herve Recipon - San Francisco CA, US
Yongming Sun - San Jose CA, US
Chenghua Liu - San Jose CA, US
Leah Turner - Sunnyvale CA, US

International Classification:

C12Q001/68
G01N033/574
C07H021/04

US Classification:

435/006000, 435/007230, 536/023200

Abstract:

The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.

US Patent:

20030064378, Apr 3, 2003

Filed:

Oct 26, 2001

Appl. No.:

10/016349

Inventors:

Herve Recipon - San Francisco CA, US
Yongming Sun - Redwood City CA, US
Chenghua Liu - San Jose CA, US
Leah Turner - Sunnyvale CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/00
C12P021/02
C12N005/06

US Classification:

435/006000, 435/069100, 435/183000, 435/320100, 435/325000, 536/023200

Abstract:

The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.

US Patent:

20030068624, Apr 10, 2003

Filed:

Oct 26, 2001

Appl. No.:

10/034934

Inventors:

Herve Recipon - San Francisco CA, US
Yongming Sun - San Jose CA, US
Chenghua Liu - San Jose CA, US
Leah Turner - Sunnyvale CA, US

International Classification:

C12Q001/68
G01N033/574
C07H021/04
C12N009/00
C12P021/02
C12N005/06

US Classification:

435/006000, 435/007230, 435/069100, 435/183000, 435/320100, 435/325000, 536/023200

Abstract:

The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.

US Patent:

20050037419, Feb 17, 2005

Filed:

Oct 5, 2004

Appl. No.:

10/958862

Inventors:

Herve Recipon - San Francisco CA, US
Yongming Sun - San Jose CA, US
Chenghua Liu - San Jose CA, US
Leah Turner - Sunnyvale CA, US

International Classification:

C12Q001/68
G01N033/574
C07H021/04
C12N009/00

US Classification:

435006000, 435007230, 435069100, 435183000, 435320100, 435325000, 536023200

Abstract:

The present invention relates to newly identified nucleic acids and polypeptides present in normal and neoplastic lung cells, including fragments, variants and derivatives of the nucleic acids and polypeptides. The present invention also relates to antibodies to the polypeptides of the invention, as well as agonists and antagonists of the polypeptides of the invention. The invention also relates to compositions comprising the nucleic acids, polypeptides, antibodies, variants, derivatives, agonists and antagonists of the invention and methods for the use of these compositions. These uses include identifying, diagnosing, monitoring, staging, imaging and treating lung cancer and non-cancerous disease states in lung, identifying lung tissue, monitoring and identifying and/or designing agonists and antagonists of polypeptides of the invention. The uses also include gene therapy, production of transgenic animals and cells, and production of engineered lung tissue for treatment and research.